DMAA, DMHA, and Novel Pre-Workout Stimulants: A Cardiac Event Waiting to Happen
DMAA (1,3-dimethylamylamine), DMHA (1,5-dimethylhexylamine), DMBA, and an ongoing rotation of "novel" stimulant amines are the chemical successors to ephedra in the pre-workout and weight-loss supplement space. Each new compound is marketed until regulators catch up, then replaced with a slightly different molecule. The pattern reflects regulatory arbitrage, not innovation.
DMAA and the Military Deaths
DMAA was implicated in the deaths of US military personnel during physical training in 2011–2012. Case reports documented myocardial infarction and haemorrhagic stroke in young healthy soldiers using DMAA-containing supplements (Jack3d, OxyElite Pro). The FDA issued warning letters in 2013 and DMAA was removed from the US supplement market — but not reliably from every product labelled as such.
DMHA and the Replacements
After DMAA was pushed out, DMHA appeared, followed by octodrine, phenylethylamine derivatives, and 1,3-DMBA. Each has a similar pharmacology: potent sympathomimetic with unclear therapeutic index and rapidly accumulating adverse event reports. The FDA has issued warning letters for DMHA. Each replacement is slightly restructured to evade regulation while preserving the stimulant effect — and the cardiovascular risk.
The Additive Stimulant Load
These compounds are typically combined with high-dose caffeine (300–400 mg), yohimbine, synephrine, and sometimes clenbuterol analogues or undeclared amphetamine-class substances. The summed effect is a substantial sympathomimetic load with unpredictable individual response, particularly in people with undiagnosed cardiac conditions.
The Product Testing Evidence
Independent analysis of pre-workout supplements regularly finds: undeclared pharmaceutical stimulants (amphetamines, ephedrine), compounds banned in sport, mislabeled ingredient content, and heavy metal contamination. A 2019 JAMA Network Open analysis found dozens of pre-workout products contained unapproved stimulants.
Warning Signs
Red flags on labels: proprietary blends that do not list individual ingredient doses; compounds ending in "-amine" that sound pharmaceutical; websites that are not the brand’s official site; claims of "stronger than banned" products; dramatic energy/focus claims that resemble ADHD medication effects; user forum mentions of "feeling tweaky" or needing cardiac medications after use.
What Is Safe
Pure caffeine (3–6 mg/kg, up to 400 mg/day), creatine monohydrate, beta-alanine, citrulline malate, and beetroot/nitrate are the evidence-based pre-workout stack. None of them require novel stimulant chemistry. Stick to products that list individual ingredient doses, are third-party tested (NSF Certified for Sport, Informed-Sport), and have simple ingredient panels.
Sources
- Cohen PA, Travis JC, Venhuis BJ. "A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement." Drug Testing and Analysis, 2014;6(7–8):805–807.
- Cohen PA, Travis JC, Keizers PHJ, Deuster P, Venhuis BJ. "Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)." Clinical Toxicology, 2018;56(6):421–426.
- Schilling BK, Hammond KG, Bloomer RJ, Presley CS, Yates CR. "Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men." BMC Pharmacology and Toxicology, 2013;14:52.
- Eliason MJ, Eichner A, Cancio A, Bestervelt L, Adams BD, Deuster PA. "Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA)." Military Medicine, 2012;177(12):1455–1459.
- Karnatovskaia LV, Leoni JC, Freeman ML. "Cardiac arrest in a 21-year-old man after ingestion of 1,3-DMAA-containing workout supplement." Clinical Journal of Sport Medicine, 2015;25(2):e23–e25.
- Cohen PA, Travis JC, Venhuis BJ. "A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements." Drug Testing and Analysis, 2015;7(1):83–87.
- U.S. Food & Drug Administration. "FDA Statement on DMAA in Dietary Supplements" (2013) and DMHA warning letters (2019–2024). FDA.gov.
- U.S. Anti-Doping Agency. "DMAA — what athletes need to know" / WADA "Prohibited List" classification of methylhexanamine (DMAA) as S6 stimulant. usada.org / wada-ama.org.
- Health Canada. "Health Canada warns Canadians about products containing DMAA" (recurring advisories 2012–2024). canada.ca/health.
Sources
- Small C, et al. "The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization." J Pharmacol Exp Ther, 2023;386(2):266-273. PMID: 37348963. DOI: 10.1124/jpet.122.001573.